If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> ARCHIVE<br /> VOLUME 110 NUMBER 1 JANUARY 2015<br /> www.amjgastro.com<br /> OFFICIAL PUBLICATION OF THE AMERICAN COLLEGE OF GASTROENTEROLOGY<br /> LEADING ARTICLES OF THE MONTH<br /> Practice Guidelines<br /> 18 ACG Clinical Guidelines: Epidemiology, Risk Factors,<br /> Patterns of Presentation, Diagnosis, and Management<br /> of Colon Ischemia (CI) CME<br /> L.J. Brandt, P. Feuerstadt, G.F. Longstreth and S.J. Boley<br /> Quality Indicators for GI Endoscopic Procedures<br /> 60 Quality Indicators for EGD<br /> W.G. Park, N.J. Shaheen, J. Cohen, I.M. Pike, D.G. Adler, J.M. Inadomi,<br /> L.A. Laine, J.G. Lieb II, M.K. Rizk, M.S. Sawhney and S. Wani<br /> 72 Quality Indicators for Colonoscopy<br /> D.K. Rex, P.S. Schoenfeld, J. Cohen, I.M. Pike, D.G. Adler, M.B. Fennerty,<br /> J.G. Lieb II, W.G. Park, M.K. Rizk, M.S. Sawhney, N.J. Shaheen, S.<a title="AJG_Vol.110.No.6 page 1" href="http://viewer.zmags.com/publication/1b35db2c?page=1"> ARCHIVE VOLUME 110 NUMBER 1 JANUARY 2015 www.am</a> <a title="AJG_Vol.110.No.6 page 2" href="http://viewer.zmags.com/publication/1b35db2c?page=2"> VOLUME 110 NUMBER 6 JUNE 2015 www.amjgastro.com </a> <a title="AJG_Vol.110.No.6 page 3" href="http://viewer.zmags.com/publication/1b35db2c?page=3"> Hepatic Encephalopathy (HE) EPISODES CAUSE COGNI</a> <a title="AJG_Vol.110.No.6 page 4" href="http://viewer.zmags.com/publication/1b35db2c?page=4"> The following is a brief summary only. See</a> <a title="AJG_Vol.110.No.6 page 5" href="http://viewer.zmags.com/publication/1b35db2c?page=5"> Unique events committed to scientific excellence </a> <a title="AJG_Vol.110.No.6 page 6" href="http://viewer.zmags.com/publication/1b35db2c?page=6"> www.amjgastro.com The American Journal of</a> <a title="AJG_Vol.110.No.6 page 7" href="http://viewer.zmags.com/publication/1b35db2c?page=7"> The person depicted is a model used for illustrat</a> <a title="AJG_Vol.110.No.6 page 8" href="http://viewer.zmags.com/publication/1b35db2c?page=8"> UC IS OVERWHELMING TREATMENT SHOULDN'T BE The inj</a> <a title="AJG_Vol.110.No.6 page 9" href="http://viewer.zmags.com/publication/1b35db2c?page=9"> IMPORTANT SAFETY INFORMATION FOR SIMPONI® (golimu</a> <a title="AJG_Vol.110.No.6 page 10" href="http://viewer.zmags.com/publication/1b35db2c?page=10"> DEMYELINATING DISORDERS TNF-blocking agents, of w</a> <a title="AJG_Vol.110.No.6 page 11" href="http://viewer.zmags.com/publication/1b35db2c?page=11"> Brief Summary of Prescribing Information for SIMP</a> <a title="AJG_Vol.110.No.6 page 12" href="http://viewer.zmags.com/publication/1b35db2c?page=12"> SIMPONI® (golimumab) represented a variety of m</a> <a title="AJG_Vol.110.No.6 page 13" href="http://viewer.zmags.com/publication/1b35db2c?page=13"> SIMPONI® (golimumab) respectively. Infections I</a> <a title="AJG_Vol.110.No.6 page 14" href="http://viewer.zmags.com/publication/1b35db2c?page=14"> SIMPONI® (golimumab) (860 times and 310 times g</a> <a title="AJG_Vol.110.No.6 page 15" href="http://viewer.zmags.com/publication/1b35db2c?page=15"> american college of gastroenterology ACG2015 Annu</a> <a title="AJG_Vol.110.No.6 page 16" href="http://viewer.zmags.com/publication/1b35db2c?page=16"> IN THE TREATMENT OF CHRONIC HEPATIT</a> <a title="AJG_Vol.110.No.6 page 17" href="http://viewer.zmags.com/publication/1b35db2c?page=17"> NO HBV RESISTANCE DEVELOPED THROUGH YEAR 7 Annual</a> <a title="AJG_Vol.110.No.6 page 18" href="http://viewer.zmags.com/publication/1b35db2c?page=18"> In clinical trials (Studies 102 and 103), no HBV </a> <a title="AJG_Vol.110.No.6 page 19" href="http://viewer.zmags.com/publication/1b35db2c?page=19"> VIREAD® (tenofovir disoproxil fumarate) tablets B</a> <a title="AJG_Vol.110.No.6 page 20" href="http://viewer.zmags.com/publication/1b35db2c?page=20"> Brief Summary (cont'd) abnormalities (Grades 3–4)</a> <a title="AJG_Vol.110.No.6 page 21" href="http://viewer.zmags.com/publication/1b35db2c?page=21"> Looking for an easy way to diagnose SIBO? %</a> <a title="AJG_Vol.110.No.6 page 22" href="http://viewer.zmags.com/publication/1b35db2c?page=22"> OFFICIAL PUBLICATION OF THE AMERICAN COLLEGE</a> <a title="AJG_Vol.110.No.6 page 23" href="http://viewer.zmags.com/publication/1b35db2c?page=23"> INDICATION AND IMPORTANT SAFETY INFORMATION FOR H</a> <a title="AJG_Vol.110.No.6 page 24" href="http://viewer.zmags.com/publication/1b35db2c?page=24"> MODERATE TO SEVERE CROHN'S DISEASE My name is S</a> <a title="AJG_Vol.110.No.6 page 25" href="http://viewer.zmags.com/publication/1b35db2c?page=25"> HUMIRA® (adalimumab) </a> <a title="AJG_Vol.110.No.6 page 26" href="http://viewer.zmags.com/publication/1b35db2c?page=26"> Autoimmunity Treatment with HUMIRA may result in </a> <a title="AJG_Vol.110.No.6 page 27" href="http://viewer.zmags.com/publication/1b35db2c?page=27"> Skin reactions: Stevens Johnson Syndrome, cutaneo</a> <a title="AJG_Vol.110.No.6 page 28" href="http://viewer.zmags.com/publication/1b35db2c?page=28"> #1 MOST PRESCRIBED, BRANDED BOWEL PREP KIT1 </a> <a title="AJG_Vol.110.No.6 page 29" href="http://viewer.zmags.com/publication/1b35db2c?page=29"> IMPORTANT SAFETY INFORMATION SUPREP® Bowel Prep K</a> <a title="AJG_Vol.110.No.6 page 30" href="http://viewer.zmags.com/publication/1b35db2c?page=30"> Albert Einstein used with permission of the HUJ/G</a> <a title="AJG_Vol.110.No.6 page 31" href="http://viewer.zmags.com/publication/1b35db2c?page=31"> HARVONI is the only HCV treatment offering an 8-w</a> <a title="AJG_Vol.110.No.6 page 32" href="http://viewer.zmags.com/publication/1b35db2c?page=32"> HARVONI is the only once-daily single-tablet regi</a> <a title="AJG_Vol.110.No.6 page 33" href="http://viewer.zmags.com/publication/1b35db2c?page=33"> HARVONI® (ledipasvir 90 mg and sofosbuvir 400 mg)</a> <a title="AJG_Vol.110.No.6 page 34" href="http://viewer.zmags.com/publication/1b35db2c?page=34"> Brief Summary (cont.) · Proton-pump inhibitors</a> <a title="AJG_Vol.110.No.6 page 35" href="http://viewer.zmags.com/publication/1b35db2c?page=35"> Michael R. Charlton, MD Mayo Clinic Rochester, MN</a> <a title="AJG_Vol.110.No.6 page 36" href="http://viewer.zmags.com/publication/1b35db2c?page=36"> The following is a brief summary only; see full P</a> <a title="AJG_Vol.110.No.6 page 37" href="http://viewer.zmags.com/publication/1b35db2c?page=37"> CRANBERRY FLAVOR NOW AVAILABLE! </a> <a title="AJG_Vol.110.No.6 page 38" href="http://viewer.zmags.com/publication/1b35db2c?page=38"> CONTENTS VOLUME 110 NUMBER 6 JUNE 2015 </a> <a title="AJG_Vol.110.No.6 page 39" href="http://viewer.zmags.com/publication/1b35db2c?page=39"> CONTENTS Symptoms Endoscopy Histology See </a> <a title="AJG_Vol.110.No.6 page 40" href="http://viewer.zmags.com/publication/1b35db2c?page=40"> www.amjgastro.com </a> <a title="AJG_Vol.110.No.6 page 41" href="http://viewer.zmags.com/publication/1b35db2c?page=41"> INTRODUCING A New Face of Cure* in HCV F</a> <a title="AJG_Vol.110.No.6 page 42" href="http://viewer.zmags.com/publication/1b35db2c?page=42"> VIEKIRA PAK +/- ribavirin (RBV) cured* chronic HC</a> <a title="AJG_Vol.110.No.6 page 43" href="http://viewer.zmags.com/publication/1b35db2c?page=43"> VIEKIRA PAKTM </a> <a title="AJG_Vol.110.No.6 page 44" href="http://viewer.zmags.com/publication/1b35db2c?page=44"> Median declines in CD4+ T-cell counts of 47 cells</a> <a title="AJG_Vol.110.No.6 page 45" href="http://viewer.zmags.com/publication/1b35db2c?page=45"> July 14th - 18th · Berlin, Germany · Maritim Hote</a> <a title="AJG_Vol.110.No.6 page 46" href="http://viewer.zmags.com/publication/1b35db2c?page=46"> GI�QUALITY�IMPROVEMENT�CONSORTIUM��LTD� 3 Se�ing</a> <a title="AJG_Vol.110.No.6 page 47" href="http://viewer.zmags.com/publication/1b35db2c?page=47"> Now, less is an option. avi y</a> <a title="AJG_Vol.110.No.6 page 48" href="http://viewer.zmags.com/publication/1b35db2c?page=48"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 49" href="http://viewer.zmags.com/publication/1b35db2c?page=49"> 782 THE RED SECTION g/g) Levels of Fecal Cal</a> <a title="AJG_Vol.110.No.6 page 50" href="http://viewer.zmags.com/publication/1b35db2c?page=50"> THE RED SECTION 783 Cyst Fluid Glucose</a> <a title="AJG_Vol.110.No.6 page 51" href="http://viewer.zmags.com/publication/1b35db2c?page=51"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 52" href="http://viewer.zmags.com/publication/1b35db2c?page=52"> 785 THE RED SECTION Esophagus The anatomy </a> <a title="AJG_Vol.110.No.6 page 53" href="http://viewer.zmags.com/publication/1b35db2c?page=53"> invasive pit patterns, and Sano’s capillary patte</a> <a title="AJG_Vol.110.No.6 page 54" href="http://viewer.zmags.com/publication/1b35db2c?page=54"> 787 THE RED SECTION </a> <a title="AJG_Vol.110.No.6 page 55" href="http://viewer.zmags.com/publication/1b35db2c?page=55"> Technique Performing ESD involves (i) accurately </a> <a title="AJG_Vol.110.No.6 page 56" href="http://viewer.zmags.com/publication/1b35db2c?page=56"> 789 THE RED SECTION </a> <a title="AJG_Vol.110.No.6 page 57" href="http://viewer.zmags.com/publication/1b35db2c?page=57"> KD-630L, Japan), Hybrid knife T-type (ERBE), and </a> <a title="AJG_Vol.110.No.6 page 58" href="http://viewer.zmags.com/publication/1b35db2c?page=58"> 791 THE RED SECTION rectal tumors as</a> <a title="AJG_Vol.110.No.6 page 59" href="http://viewer.zmags.com/publication/1b35db2c?page=59"> 792 THE RED SECTION </a> <a title="AJG_Vol.110.No.6 page 60" href="http://viewer.zmags.com/publication/1b35db2c?page=60"> showed an infertility rate of 7% in UC patients w</a> <a title="AJG_Vol.110.No.6 page 61" href="http://viewer.zmags.com/publication/1b35db2c?page=61"> 794 THE RED SECTION </a> <a title="AJG_Vol.110.No.6 page 62" href="http://viewer.zmags.com/publication/1b35db2c?page=62"> Table 2. Disease characteristics of participants </a> <a title="AJG_Vol.110.No.6 page 63" href="http://viewer.zmags.com/publication/1b35db2c?page=63"> 796 THE RED SECTION </a> <a title="AJG_Vol.110.No.6 page 64" href="http://viewer.zmags.com/publication/1b35db2c?page=64"> Laura E. Dodge, MPH:Statistical support, planning</a> <a title="AJG_Vol.110.No.6 page 65" href="http://viewer.zmags.com/publication/1b35db2c?page=65"> 798 THE RED SECTION </a> <a title="AJG_Vol.110.No.6 page 66" href="http://viewer.zmags.com/publication/1b35db2c?page=66"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 67" href="http://viewer.zmags.com/publication/1b35db2c?page=67"> 800 THE RED SECTION </a> <a title="AJG_Vol.110.No.6 page 68" href="http://viewer.zmags.com/publication/1b35db2c?page=68"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 69" href="http://viewer.zmags.com/publication/1b35db2c?page=69"> 802 CLINICAL AND SYSTEMATIC REVIEWS </a> <a title="AJG_Vol.110.No.6 page 70" href="http://viewer.zmags.com/publication/1b35db2c?page=70"> include high cost, constrained availability, and </a> <a title="AJG_Vol.110.No.6 page 71" href="http://viewer.zmags.com/publication/1b35db2c?page=71"> 804 Mosli et al. REVIEW screened), baseline</a> <a title="AJG_Vol.110.No.6 page 72" href="http://viewer.zmags.com/publication/1b35db2c?page=72"> Biomarkers for Evaluating Endoscopic Disease Acti</a> <a title="AJG_Vol.110.No.6 page 73" href="http://viewer.zmags.com/publication/1b35db2c?page=73"> 806 Mosli et al. StudyId Karoui 2011</a> <a title="AJG_Vol.110.No.6 page 74" href="http://viewer.zmags.com/publication/1b35db2c?page=74"> Biomarkers for Evaluating Endoscopic Disease Acti</a> <a title="AJG_Vol.110.No.6 page 75" href="http://viewer.zmags.com/publication/1b35db2c?page=75"> 808 Mosli et al. StudyId REVIEW </a> <a title="AJG_Vol.110.No.6 page 76" href="http://viewer.zmags.com/publication/1b35db2c?page=76"> Biomarkers for Evaluating Endoscopic Disease Acti</a> <a title="AJG_Vol.110.No.6 page 77" href="http://viewer.zmags.com/publication/1b35db2c?page=77"> 810 Mosli et al. StudyId Sippoen 20</a> <a title="AJG_Vol.110.No.6 page 78" href="http://viewer.zmags.com/publication/1b35db2c?page=78"> Biomarkers for Evaluating Endoscopic Disease Acti</a> <a title="AJG_Vol.110.No.6 page 79" href="http://viewer.zmags.com/publication/1b35db2c?page=79"> 812 Mosli et al. REVIEW Table 3. Continued </a> <a title="AJG_Vol.110.No.6 page 80" href="http://viewer.zmags.com/publication/1b35db2c?page=80"> 1.0 Sensitivity 0.5 0.0 Observed da</a> <a title="AJG_Vol.110.No.6 page 81" href="http://viewer.zmags.com/publication/1b35db2c?page=81"> Univariable meta-regression and subgroup analyses</a> <a title="AJG_Vol.110.No.6 page 82" href="http://viewer.zmags.com/publication/1b35db2c?page=82"> Biomarkers for Evaluating Endoscopic Disease Acti</a> <a title="AJG_Vol.110.No.6 page 83" href="http://viewer.zmags.com/publication/1b35db2c?page=83"> 816 Mosli et al. REVIEW Table 4. Test predi</a> <a title="AJG_Vol.110.No.6 page 84" href="http://viewer.zmags.com/publication/1b35db2c?page=84"> endoscopy was utilized and the relatively large s</a> <a title="AJG_Vol.110.No.6 page 85" href="http://viewer.zmags.com/publication/1b35db2c?page=85"> 818 Mosli et al. REVIEW Study Highlights W</a> <a title="AJG_Vol.110.No.6 page 86" href="http://viewer.zmags.com/publication/1b35db2c?page=86"> 36. Higgins JP, Thompson SG. Quantifying heteroge</a> <a title="AJG_Vol.110.No.6 page 87" href="http://viewer.zmags.com/publication/1b35db2c?page=87"> 820 CLINICAL AND SYSTEMATIC REVIEWS </a> <a title="AJG_Vol.110.No.6 page 88" href="http://viewer.zmags.com/publication/1b35db2c?page=88"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 89" href="http://viewer.zmags.com/publication/1b35db2c?page=89"> 822 Dellon et al. ESOPHAGUS Candidate bio</a> <a title="AJG_Vol.110.No.6 page 90" href="http://viewer.zmags.com/publication/1b35db2c?page=90"> were measured using an 8-plex panel (cat # HCYTOM</a> <a title="AJG_Vol.110.No.6 page 91" href="http://viewer.zmags.com/publication/1b35db2c?page=91"> 824 Dellon et al. 10,000 1,000 100 </a> <a title="AJG_Vol.110.No.6 page 92" href="http://viewer.zmags.com/publication/1b35db2c?page=92"> 10,000 Concentration (pg/ml*) 1,000 100 1</a> <a title="AJG_Vol.110.No.6 page 93" href="http://viewer.zmags.com/publication/1b35db2c?page=93"> 826 Dellon et al. ESOPHAGUS CONFLICT OF INT</a> <a title="AJG_Vol.110.No.6 page 94" href="http://viewer.zmags.com/publication/1b35db2c?page=94"> 27. Blanchard C, Stucke EM, Burwinkel K et al. Co</a> <a title="AJG_Vol.110.No.6 page 95" href="http://viewer.zmags.com/publication/1b35db2c?page=95"> 828 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.110.No.6 page 96" href="http://viewer.zmags.com/publication/1b35db2c?page=96"> Endoscopic screening and surveillance relies </a> <a title="AJG_Vol.110.No.6 page 97" href="http://viewer.zmags.com/publication/1b35db2c?page=97"> 830 Eluri et al. ESOPHAGUS of the DNA had L</a> <a title="AJG_Vol.110.No.6 page 98" href="http://viewer.zmags.com/publication/1b35db2c?page=98"> Table 2. Mutational load (ML) performance charact</a> <a title="AJG_Vol.110.No.6 page 99" href="http://viewer.zmags.com/publication/1b35db2c?page=99"> 832 Eluri et al. ESOPHAGUS assay’s accuracy</a> <a title="AJG_Vol.110.No.6 page 100" href="http://viewer.zmags.com/publication/1b35db2c?page=100"> Study Highlights WHAT IS CURRENT KNOWLEDGE ✓ Bar</a> <a title="AJG_Vol.110.No.6 page 101" href="http://viewer.zmags.com/publication/1b35db2c?page=101"> 834 Eluri et al. ESOPHAGUS 41. Reid BJ, Pre</a> <a title="AJG_Vol.110.No.6 page 102" href="http://viewer.zmags.com/publication/1b35db2c?page=102"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 103" href="http://viewer.zmags.com/publication/1b35db2c?page=103"> 836 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.110.No.6 page 104" href="http://viewer.zmags.com/publication/1b35db2c?page=104"> HCC surveillance in high-risk patients with an in</a> <a title="AJG_Vol.110.No.6 page 105" href="http://viewer.zmags.com/publication/1b35db2c?page=105"> 838 Chang et al. Patients with cirrhosis f</a> <a title="AJG_Vol.110.No.6 page 106" href="http://viewer.zmags.com/publication/1b35db2c?page=106"> AFP for HCC Surveillance 839 Table 1. Basel</a> <a title="AJG_Vol.110.No.6 page 107" href="http://viewer.zmags.com/publication/1b35db2c?page=107"> 840 Chang et al. LIVER Table 3. Factors pre</a> <a title="AJG_Vol.110.No.6 page 108" href="http://viewer.zmags.com/publication/1b35db2c?page=108"> AFP for HCC Surveillance 841 1 Sensitiv</a> <a title="AJG_Vol.110.No.6 page 109" href="http://viewer.zmags.com/publication/1b35db2c?page=109"> 842 Chang et al. LIVER Table 4. Performance</a> <a title="AJG_Vol.110.No.6 page 110" href="http://viewer.zmags.com/publication/1b35db2c?page=110"> with cirrhosis unrelated to viral hepatitis in co</a> <a title="AJG_Vol.110.No.6 page 111" href="http://viewer.zmags.com/publication/1b35db2c?page=111"> 844 Chang et al. LIVER 17. Ishikawa K, Sasa</a> <a title="AJG_Vol.110.No.6 page 112" href="http://viewer.zmags.com/publication/1b35db2c?page=112"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 113" href="http://viewer.zmags.com/publication/1b35db2c?page=113"> 846 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.110.No.6 page 114" href="http://viewer.zmags.com/publication/1b35db2c?page=114"> INTRODUCTION Alcohol abuse is a common cause of c</a> <a title="AJG_Vol.110.No.6 page 115" href="http://viewer.zmags.com/publication/1b35db2c?page=115"> 848 Salameh et al. LIVER ured within the se</a> <a title="AJG_Vol.110.No.6 page 116" href="http://viewer.zmags.com/publication/1b35db2c?page=116"> PNPLA3 Polymorphisms and Alcoholic Liver Disease </a> <a title="AJG_Vol.110.No.6 page 117" href="http://viewer.zmags.com/publication/1b35db2c?page=117"> 850 Salameh et al. with AFL (1 study), AL</a> <a title="AJG_Vol.110.No.6 page 118" href="http://viewer.zmags.com/publication/1b35db2c?page=118"> genotype was 12.41 (6.99–22.03) as compared with </a> <a title="AJG_Vol.110.No.6 page 119" href="http://viewer.zmags.com/publication/1b35db2c?page=119"> 852 Salameh et al. heterogeneity (I2=20.3</a> <a title="AJG_Vol.110.No.6 page 120" href="http://viewer.zmags.com/publication/1b35db2c?page=120"> PNPLA3 Polymorphisms and Alcoholic Liver Disease </a> <a title="AJG_Vol.110.No.6 page 121" href="http://viewer.zmags.com/publication/1b35db2c?page=121"> 854 Salameh et al. Table 3. Generalized line</a> <a title="AJG_Vol.110.No.6 page 122" href="http://viewer.zmags.com/publication/1b35db2c?page=122"> Study Highlights WHAT IS CURRENT KNOWLEDGE ✓ The</a> <a title="AJG_Vol.110.No.6 page 123" href="http://viewer.zmags.com/publication/1b35db2c?page=123"> 856 Salameh et al. LIVER 44. Lane BP, Liebe</a> <a title="AJG_Vol.110.No.6 page 124" href="http://viewer.zmags.com/publication/1b35db2c?page=124"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 125" href="http://viewer.zmags.com/publication/1b35db2c?page=125"> 858 Umemura et al. LIVER sive methods are u</a> <a title="AJG_Vol.110.No.6 page 126" href="http://viewer.zmags.com/publication/1b35db2c?page=126"> the Mann–Whitney U-test. Spearman’s rank order co</a> <a title="AJG_Vol.110.No.6 page 127" href="http://viewer.zmags.com/publication/1b35db2c?page=127"> 860 Umemura et al. 12.0 10.0 8.0 LI</a> <a title="AJG_Vol.110.No.6 page 128" href="http://viewer.zmags.com/publication/1b35db2c?page=128"> Predictive Abilities of WFA+-M2BP in PBC 861 </a> <a title="AJG_Vol.110.No.6 page 129" href="http://viewer.zmags.com/publication/1b35db2c?page=129"> 862 Umemura et al. 1.0 WFA+-M2BP < 2.0 </a> <a title="AJG_Vol.110.No.6 page 130" href="http://viewer.zmags.com/publication/1b35db2c?page=130"> fibrosis; however, risk score at diagnosis was no</a> <a title="AJG_Vol.110.No.6 page 131" href="http://viewer.zmags.com/publication/1b35db2c?page=131"> 864 Umemura et al. LIVER 12. Yamasaki K, Ta</a> <a title="AJG_Vol.110.No.6 page 132" href="http://viewer.zmags.com/publication/1b35db2c?page=132"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 133" href="http://viewer.zmags.com/publication/1b35db2c?page=133"> 866 Boschetti et al. INFLAMMATORY BOWEL DISE</a> <a title="AJG_Vol.110.No.6 page 134" href="http://viewer.zmags.com/publication/1b35db2c?page=134"> or skip areas of larger lesions or lesions confin</a> <a title="AJG_Vol.110.No.6 page 135" href="http://viewer.zmags.com/publication/1b35db2c?page=135"> 100 10 Endoscopic </a> <a title="AJG_Vol.110.No.6 page 136" href="http://viewer.zmags.com/publication/1b35db2c?page=136"> Fecal calprotectin in CD after surgery 869 </a> <a title="AJG_Vol.110.No.6 page 137" href="http://viewer.zmags.com/publication/1b35db2c?page=137"> fCal (AUC = 0.86) hsCRP (AUC = 0.70) 870 Bos</a> <a title="AJG_Vol.110.No.6 page 138" href="http://viewer.zmags.com/publication/1b35db2c?page=138"> patients underwent an endoscopic assessment; in a</a> <a title="AJG_Vol.110.No.6 page 139" href="http://viewer.zmags.com/publication/1b35db2c?page=139"> 872 Boschetti et al. INFLAMMATORY BOWEL DISE</a> <a title="AJG_Vol.110.No.6 page 140" href="http://viewer.zmags.com/publication/1b35db2c?page=140"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 141" href="http://viewer.zmags.com/publication/1b35db2c?page=141"> 874 Takashima et al. INFLAMMATORY BOWEL DISE</a> <a title="AJG_Vol.110.No.6 page 142" href="http://viewer.zmags.com/publication/1b35db2c?page=142"> Fecal Calprotectin Vs. FIT for Mucosal Healing </a> <a title="AJG_Vol.110.No.6 page 143" href="http://viewer.zmags.com/publication/1b35db2c?page=143"> 876 Takashima et al. INFLAMMATORY BOWEL DISE</a> <a title="AJG_Vol.110.No.6 page 144" href="http://viewer.zmags.com/publication/1b35db2c?page=144"> ng/ml 100,000 10,000 1,000 Fecal concentrat</a> <a title="AJG_Vol.110.No.6 page 145" href="http://viewer.zmags.com/publication/1b35db2c?page=145"> 878 Takashima et al. ng/ml 100,000 </a> <a title="AJG_Vol.110.No.6 page 146" href="http://viewer.zmags.com/publication/1b35db2c?page=146"> Table 6. Sensitivity, specificity, and predictive </a> <a title="AJG_Vol.110.No.6 page 147" href="http://viewer.zmags.com/publication/1b35db2c?page=147"> 880 Takashima et al. INFLAMMATORY BOWEL DISE</a> <a title="AJG_Vol.110.No.6 page 148" href="http://viewer.zmags.com/publication/1b35db2c?page=148"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 149" href="http://viewer.zmags.com/publication/1b35db2c?page=149"> 882 Yamamoto et al. INFLAMMATORY BOWEL DISEA</a> <a title="AJG_Vol.110.No.6 page 150" href="http://viewer.zmags.com/publication/1b35db2c?page=150"> Lf-Plus, Alfresa Pharma, Osaka, Japan) by using a</a> <a title="AJG_Vol.110.No.6 page 151" href="http://viewer.zmags.com/publication/1b35db2c?page=151"> 884 Yamamoto et al. 250 </a> <a title="AJG_Vol.110.No.6 page 152" href="http://viewer.zmags.com/publication/1b35db2c?page=152"> Calprotectin 1.01.0 0.80.8 0.60.6 True posit</a> <a title="AJG_Vol.110.No.6 page 153" href="http://viewer.zmags.com/publication/1b35db2c?page=153"> Calprotectin 250 200 µg/g 150 100 50 886 </a> <a title="AJG_Vol.110.No.6 page 154" href="http://viewer.zmags.com/publication/1b35db2c?page=154"> after restorative proctocolectomy. Consecutive mo</a> <a title="AJG_Vol.110.No.6 page 155" href="http://viewer.zmags.com/publication/1b35db2c?page=155"> 888 EDITORIAL </a> <a title="AJG_Vol.110.No.6 page 156" href="http://viewer.zmags.com/publication/1b35db2c?page=156"> Symptoms Endoscopy Histology Invasiveness and co</a> <a title="AJG_Vol.110.No.6 page 157" href="http://viewer.zmags.com/publication/1b35db2c?page=157"> 890 Schoepfer and Reinisch INFLAMMATORY BOWE</a> <a title="AJG_Vol.110.No.6 page 158" href="http://viewer.zmags.com/publication/1b35db2c?page=158"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 159" href="http://viewer.zmags.com/publication/1b35db2c?page=159"> 892 Di Stefano et al. FUNCTIONAL GI DISORDER</a> <a title="AJG_Vol.110.No.6 page 160" href="http://viewer.zmags.com/publication/1b35db2c?page=160"> to estimate cumulative intestinal gas excretion b</a> <a title="AJG_Vol.110.No.6 page 161" href="http://viewer.zmags.com/publication/1b35db2c?page=161"> 894 Di Stefano et al. GI DISORDERS FUNCTIONA</a> <a title="AJG_Vol.110.No.6 page 162" href="http://viewer.zmags.com/publication/1b35db2c?page=162"> 1,600 1,400 1,200 production 1,000 Average</a> <a title="AJG_Vol.110.No.6 page 163" href="http://viewer.zmags.com/publication/1b35db2c?page=163"> 896 Di Stefano et al. FUNCTIONAL GI DISORDER</a> <a title="AJG_Vol.110.No.6 page 164" href="http://viewer.zmags.com/publication/1b35db2c?page=164"> flow (35). Consequently, when gas is rapidly prod</a> <a title="AJG_Vol.110.No.6 page 165" href="http://viewer.zmags.com/publication/1b35db2c?page=165"> 898 Di Stefano et al. FUNCTIONAL GI DISORDER</a> <a title="AJG_Vol.110.No.6 page 166" href="http://viewer.zmags.com/publication/1b35db2c?page=166"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 167" href="http://viewer.zmags.com/publication/1b35db2c?page=167"> 900 Wei et al. COLON/SMALL BOWEL developing</a> <a title="AJG_Vol.110.No.6 page 168" href="http://viewer.zmags.com/publication/1b35db2c?page=168"> (AKTApurifier 10, GE Healthcare, Piscataway, NJ) </a> <a title="AJG_Vol.110.No.6 page 169" href="http://viewer.zmags.com/publication/1b35db2c?page=169"> 902 Wei et al. G12 ELISA, samples were di</a> <a title="AJG_Vol.110.No.6 page 170" href="http://viewer.zmags.com/publication/1b35db2c?page=170"> A 219 nm (mAU) 3,500 3,000 2,500 2,000 1,500 1,0</a> <a title="AJG_Vol.110.No.6 page 171" href="http://viewer.zmags.com/publication/1b35db2c?page=171"> pH 4.0 G+F4 G only M 0 2 5 24 </a> <a title="AJG_Vol.110.No.6 page 172" href="http://viewer.zmags.com/publication/1b35db2c?page=172"> mVolts 6 t 5 t=0.5 h </a> <a title="AJG_Vol.110.No.6 page 173" href="http://viewer.zmags.com/publication/1b35db2c?page=173"> 906 Wei et al. the P1 position and a phen</a> <a title="AJG_Vol.110.No.6 page 174" href="http://viewer.zmags.com/publication/1b35db2c?page=174"> Glia Glia+lasB kDa 0 0.5 2.0 </a> <a title="AJG_Vol.110.No.6 page 175" href="http://viewer.zmags.com/publication/1b35db2c?page=175"> 908 Wei et al. COLON/SMALL BOWEL REFERENCES</a> <a title="AJG_Vol.110.No.6 page 176" href="http://viewer.zmags.com/publication/1b35db2c?page=176"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 177" href="http://viewer.zmags.com/publication/1b35db2c?page=177"> 910 Zikos et al. PANCREAS AND BILIARY TRACT </a> <a title="AJG_Vol.110.No.6 page 178" href="http://viewer.zmags.com/publication/1b35db2c?page=178"> difference being the glucometer performed better </a> <a title="AJG_Vol.110.No.6 page 179" href="http://viewer.zmags.com/publication/1b35db2c?page=179"> 912 Zikos et al. PANCREAS AND BILIARY TRACT </a> <a title="AJG_Vol.110.No.6 page 180" href="http://viewer.zmags.com/publication/1b35db2c?page=180"> Glucose Diagnoses Mucinous Pancreatic Cysts 91</a> <a title="AJG_Vol.110.No.6 page 181" href="http://viewer.zmags.com/publication/1b35db2c?page=181"> 914 Zikos et al. PANCREAS AND BILIARY TRACT </a> <a title="AJG_Vol.110.No.6 page 182" href="http://viewer.zmags.com/publication/1b35db2c?page=182"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 183" href="http://viewer.zmags.com/publication/1b35db2c?page=183"> 916 Hadley et al. PEDIATRICS INTRODUCTION C</a> <a title="AJG_Vol.110.No.6 page 184" href="http://viewer.zmags.com/publication/1b35db2c?page=184"> who tested persistently positive for tTGA in two </a> <a title="AJG_Vol.110.No.6 page 185" href="http://viewer.zmags.com/publication/1b35db2c?page=185"> 918 Hadley et al. PEDIATRICS Table 4. Allel</a> <a title="AJG_Vol.110.No.6 page 186" href="http://viewer.zmags.com/publication/1b35db2c?page=186"> may develop transient tTGAs that fade in titer wi</a> <a title="AJG_Vol.110.No.6 page 187" href="http://viewer.zmags.com/publication/1b35db2c?page=187"> 920 Hadley et al. PEDIATRICS CONFLICT OF IN</a> <a title="AJG_Vol.110.No.6 page 188" href="http://viewer.zmags.com/publication/1b35db2c?page=188"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 189" href="http://viewer.zmags.com/publication/1b35db2c?page=189"> 922 Kolho et al. PEDIATRICS inflammation, a</a> <a title="AJG_Vol.110.No.6 page 190" href="http://viewer.zmags.com/publication/1b35db2c?page=190"> Table 1. Background characteristics of pediatric </a> <a title="AJG_Vol.110.No.6 page 191" href="http://viewer.zmags.com/publication/1b35db2c?page=191"> 924 Kolho et al. as a function of the rel</a> <a title="AJG_Vol.110.No.6 page 192" href="http://viewer.zmags.com/publication/1b35db2c?page=192"> Enterobacteria ClostridiumIV Principal coordinat</a> <a title="AJG_Vol.110.No.6 page 193" href="http://viewer.zmags.com/publication/1b35db2c?page=193"> 926 Kolho et al. a 8 6 4 2 log (c</a> <a title="AJG_Vol.110.No.6 page 194" href="http://viewer.zmags.com/publication/1b35db2c?page=194"> a 1000 800 600 400 Calprotectin 3 months </a> <a title="AJG_Vol.110.No.6 page 195" href="http://viewer.zmags.com/publication/1b35db2c?page=195"> 928 Kolho et al. a 1000 800 600 400</a> <a title="AJG_Vol.110.No.6 page 196" href="http://viewer.zmags.com/publication/1b35db2c?page=196"> ACKNOWLEDGMENTS RN Anne Nikkonen is thanked for h</a> <a title="AJG_Vol.110.No.6 page 197" href="http://viewer.zmags.com/publication/1b35db2c?page=197"> 930 Kolho et al. PEDIATRICS 26. Png CW, Lin</a> <a title="AJG_Vol.110.No.6 page 198" href="http://viewer.zmags.com/publication/1b35db2c?page=198"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 199" href="http://viewer.zmags.com/publication/1b35db2c?page=199"> 932 Letters to the Editor </a> <a title="AJG_Vol.110.No.6 page 200" href="http://viewer.zmags.com/publication/1b35db2c?page=200"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 201" href="http://viewer.zmags.com/publication/1b35db2c?page=201"> 934 Letters to the Editor b 1.0 0.8 0</a> <a title="AJG_Vol.110.No.6 page 202" href="http://viewer.zmags.com/publication/1b35db2c?page=202"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 203" href="http://viewer.zmags.com/publication/1b35db2c?page=203"> 936 Letters to the Editor </a> <a title="AJG_Vol.110.No.6 page 204" href="http://viewer.zmags.com/publication/1b35db2c?page=204"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 205" href="http://viewer.zmags.com/publication/1b35db2c?page=205"> 938 Letters to the Editor </a> <a title="AJG_Vol.110.No.6 page 206" href="http://viewer.zmags.com/publication/1b35db2c?page=206"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 207" href="http://viewer.zmags.com/publication/1b35db2c?page=207"> 940 Letters to the Editor </a> <a title="AJG_Vol.110.No.6 page 208" href="http://viewer.zmags.com/publication/1b35db2c?page=208"> nature publishing group </a> <a title="AJG_Vol.110.No.6 page 209" href="http://viewer.zmags.com/publication/1b35db2c?page=209"> 942 ERRATA, CORRIGENDA, RETRACTIONS AND ADDEND</a> <a title="AJG_Vol.110.No.6 page 210" href="http://viewer.zmags.com/publication/1b35db2c?page=210"> Errata, Corrigenda, Retractions and Addenda 94</a> <a title="AJG_Vol.110.No.6 page 211" href="http://viewer.zmags.com/publication/1b35db2c?page=211"> NEWS & VIEWS Essential reading for all scientist</a> <a title="AJG_Vol.110.No.6 page 212" href="http://viewer.zmags.com/publication/1b35db2c?page=212"> CLASSIFIEDS imagine Gastroenterologist (Motility</a> <a title="AJG_Vol.110.No.6 page 213" href="http://viewer.zmags.com/publication/1b35db2c?page=213"> General Gastroenterology/Advanced Endoscopy </a> <a title="AJG_Vol.110.No.6 page 214" href="http://viewer.zmags.com/publication/1b35db2c?page=214"> Advanced Therapeutic Endoscopist NorthShore Univ</a> <a title="AJG_Vol.110.No.6 page 215" href="http://viewer.zmags.com/publication/1b35db2c?page=215"> SOCIAL SELECTION Nature's snapshot of science on </a> <a title="AJG_Vol.110.No.6 page 216" href="http://viewer.zmags.com/publication/1b35db2c?page=216"> Q&A: ADVERTORIAL Fecal Lactoferrin </a> <a title="AJG_Vol.110.No.6 page 217" href="http://viewer.zmags.com/publication/1b35db2c?page=217"> Adding painless, non-surgical hemorrhoid </a>